Search Results - "Janinis, J."

The pharmacological treatment of aggressive fibromatosis: a systematic review by Janinis, J., Patriki, M., Vini, L., Aravantinos, G., Whelan, J. S.

“…Background: Despite the use of surgery and radiotherapy, 20–35% of patients with aggressive fibromatosis (AF) will have local recurrence. The purpose of this…”
Get full text

Effects of epoetin-alpha on quality of life of cancer patients with solid tumors receiving chemotherapy by Christodoulou, C, Dafni, U, Aravantinos, G, Koutras, A, Samantas, E, Karina, M, Janinis, J, Papakostas, P, Skarlos, D, Kalofonos, H P, Fountzilas, G

“…Erythropoietin corrects and prevents anemia and decreases the need for red blood cell (RBC) transfusions; its impact on quality of life (QOL) of cancer…”
Get full text

A systematic review of the role of pulmonary irradiation in the management of primary bone tumours by Whelan, J. S., Burcombe, R. J., Janinis, J., Baldelli, A. M., Cassoni, A. M.

“…Introduction Adjuvant therapy in osteosarcoma (OS) and Ewing’s sarcoma (ES) is primarily directed towards treatment of subclinical lung disease. Before the…”
Get full text

Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study by Janinis, J., Papakostas, P., Samelis, G., Skarlos, D., Papagianopoulos, P., Fountzilas, G.

“…Backround: Oxaliplatin is a novel platinum derivative, which, combined with 5-fluorouracil (5-FU), and folinic acid (FA), demonstrates synergistic activity in…”
Get full text

A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma by Janinis, J., McTiernan, A., Driver, D., Mitchell, C., Cassoni, A. M., Pringle, J., Kilby, A., Whelan, J. S.

“…Background: This pilot study was undertaken to assess the feasibility, toxicity and response to short-course multiagent chemotherapy followed by high-dose…”
Get full text

Docetaxel, cisplatin, fluorouracil, and leucovorin in locally advanced head and neck cancer by Janinis, J, Panagos, G

Get full text

Abstracts Colorectal Games, Rethymnom, Crete, Greece, May 2008 by Suleiman, S. H., Salim, O. E. H., Yousif, D. O., Eltahir, M. A., Elzaki, K., Ibrahim, S. Z., Ahmed, K. M., Mudawi, H. M., Vini, L., Silyvridou, A., Kakana, C., Janinis, J., Diamantidou, E., Navrozidou, C., Boulogianni, G., Hourmouzi, D., Kopanakis, K., Macheras, A., Charalabopoulos, A., Bistarakis, D., Xylardistos, P., Shizas, D., Petropoulos, K., Bakopoulos, A., Liakakos, T., Oikonomopoulos, N., Martikos, G., Patapis, P., Misiakos, E., Tsapralis, D., Azas, A., Charalobopoulos, A., Liakakos, L., Millo, P., Allieta, R., Nardi, M., Brachet Contul, R., Scozzari, G., Alexandrou, I., Lainakis, N., Efstathiou, E., Demetriadis, D., Dolatzas, Th, Antypas, S., Parini, U., Persico, F., Loffredo, A., Lale Murix, E., Fabozzi, M., Roveroni, M., Usai, A., Da Broi, J., Nardi, M. J., Roustanis, E., Benetatos, N., Pappas-Gogos, G., Tsimogiannis, K. E., Tsimoyiannis, E. C., Pramateftakis, M. G., Mantzoros, I., Kanellos, I., Demetriades, H., Angelopoulos, S., Despoudi, K., Lazarides, H., Tsachalis, T., Sapidis, N., Gouvas, N., Tsiaoussis, J., Pechlivanides, G., Zervakis, N., Xynos, E.

Get full text

A Phase II Study with CPT-11 Plus Leucovorin and Bolus IV 5-Fluorouracil in Patients with Advanced Colorectal Carcinoma by Kalofonos, H. P., Skarlos, D., Bafaloukos, D., Papakostas, P., Bamias, A., Janinis, J., Timotheadou, E., Kouvatseas, G., Stavropoulos, M., Economopulos, T., Fountzilas, G.

“…Standard chemotherapy in advanced colorectal carcinoma (CRC) has not yet been established. The present study was conducted to assess the efficacy and toxicity…”
Get full text

The immunohistochemical expression of proliferating cell nuclear antigen (PCNA/cyclin) in malignant and benign epithelial ovarian neoplasms and correlation with prognosis by Nakopoulou, L, Janinis, J, Panagos, G, Comin, G, Davaris, P

“…Proliferating cell nuclear antigen (PCNA)/cyclin is considered to be a marker of cell proliferation. The aim of this study was to evaluate the expression of…”
Get more information

Immunohistochemical expression of p53 protein and proliferating cell nuclear antigen in hepatocellular carcinoma by Nakopoulou, L., Janinis, J., Giannopoulou, I., Lazaris, A.C., Koureas, A., Zacharoulis, D.

“…There is an increased prevalence o f p53 mutations in hepatocellular carcinomas (HCCs). A total o f 62 HCC samples with adjacent liver tissue were analyzed…”
Get full text

Stevens-Johnson syndrome and epidermal necrolysis after administration of sodium phenytoin with cranial irradiation by Janinis, J, Panagos, G, Panousaki, A, Skarlos, D, Athanasiou, E, Karpasitis, N, Pirounaki, M

Get more information

Immunohistochemical expression of EGF-R in malignant surface epithelial ovarian neoplasms (SEON) by Janinis, J, Nakopoulou, L, Panagos, G, Davaris, P

“…EGF-R expression was found to be increased in 40% of malignant epithelial ovarian neoplasms by an immunohistochemical method. No correlation was found between…”
Get more information

Management of bone loss in breast cancer patients: 24-month results from the ARBI trial of anastrozole with risedronate by Markopoulos, C., Tzorakoleftherakis, E., Polychronis, A., Venizelos, V., Xepapadakis, G., Kalogerakos, K., Papadiamantis, J., Zobolas, V., Janinis, J., Dafni, U.

“…Abstract only 552 Background: The management of bone mineral density (BMD) in postmenopausal, breast cancer (BC) patients (pts) receiveing anastrozole was…”
Get full text

Extent of bronchioloalveolar pattern and expression of the epidermal growth factor receptor in surgically resected lung adenocarcinomas by Dahabreh, I. J., Janinis, J., Karagiani, E. A., Dountsis, A., Vasilikos, K., Spiliadi, H. T.

“…Abstract only 20065 Background: An increasing number of studies are exploring relations between the bronchioloalveolar differentiation of adenocarcinomas and…”
Get full text

Effects of Epoetin-α on Quality of Life of Cancer Patients with Solid Tumors Receiving Chemotherapy by C. CHRISTODOULOU, U. DAFNI, G. ARAVANTINOS, A. KOUTRAS, E. SAMANTAS, M. KARINA, J. JANINIS, P. PAPAKOSTAS, D. SKARLOS, H.P. KALOFONOS, G. FOUNTZILAS

“…Background: Erythropoietin corrects and prevents anemia and decreases the need for red blood cell (RBC) transfusions; its impact on quality of life (QOL) of…”
Get full text

Effects of Epoetin-a on Quality of Life of Cancer Patients with Solid Tumors Receiving Chemotherapy by CHRISTODOULOU, C, DAFNI, U, FOUNTZILAS, G, ARAVANTINOS, G, KOUTRAS, A, SAMANTAS, E, KARINA, M, JANINIS, J, PAPAKOSTAS, P, SKARLOS, D, KALOFONOS, H. P

Get full text

Somatic mutations of EGFR and KRAS in pure bronchioloalveolar carcinomas and adenocarcinomas of the lung with bronchioloalveolar features by Dahabreh, I. J., Murray, S., Spiliadi, H. T., Karagiani, E. A., Stamatelopoulos, A., Vassilikos, K., Zanos, G., Janinis, J., Dahabreh, J.

“…Abstract only 21111 Background: EGFR mutations are more common in lung cancers from female, non-smoking patients of Asian ethnicity with adenocarcinoma…”
Get full text

Combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer : A phase II feasibility study by JANINIS, J, PAPADAKOU, M, XIDAKIS, E, BOUKIS, H, POULIS, A, PANAGOS, G, LEFANTZIS, D

“…The purpose of this phase II feasibility trial was to determine the efficacy and toxicity of docetaxel combined with cisplatin and 5-fluorouracil in patients…”
Get full text

Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients by Galani, Eleni, Sgouros, Joseph, Petropoulou, Chariklia, Janinis, Jim, Aravantinos, Gerassimos, Dionysiou-Asteriou, Dionysia, Skarlos, Demosthenes, Gonos, Efstathios

“…The development of a molecular screening method for cancer patients is of great importance, since it would contribute to the selection of the most effective…”
Get more information

Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer by JANINIS, Jim, PAPADAKOU, Maria, PANAGOS, Gerassimos, PANOUSAKI, Aikaterini, GEORGOULIAS, Vasilios, HATZIDAKI, Dora, LEFANTZIS, Dimitrios, DOKIANAKIS, Georgios

“…The purpose of this phase II trial was to evaluate the toxicity of a sequential chemoradiotherapy approach using docetaxel, cisplatin, and 5-fluorouracil…”
Get full text